乳糜泻治疗中的非饮食方法。
Non-dietary methods in the treatment of celiac disease.
作者信息
Szaflarska-Popławska Anna
机构信息
Department of Paediatric Endoscopy and Gastrointestinal Function Testing, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland.
出版信息
Prz Gastroenterol. 2015;10(1):12-7. doi: 10.5114/pg.2014.47503. Epub 2015 Jan 14.
Abstract
This is a selective review of the literature concerning the methods of celiac disease treatment, which can be an alternative to a gluten-free diet. The most advanced studies are devoted to the larazotide acetate (AT-1001, human zonulin inhibitor) and prolyl-endopeptidases degrading toxic gluten peptides (ALV003, AN-PEP). It is estimated that they will be registered within a few years. They will not become an alternative to the gluten-free diet but rather a supplement to it, which will enable patients to ease the nutritional restrictions.
摘要
这是一篇关于乳糜泻治疗方法的文献综述，这些方法可作为无麸质饮食的替代方案。最前沿的研究集中在醋酸拉佐肽（AT-1001，人zonulin抑制剂）和降解有毒麸质肽的脯氨酰内肽酶（ALV003，AN-PEP）上。据估计，它们将在几年内获批上市。它们不会成为无麸质饮食的替代品，而是其补充剂，这将使患者能够减轻营养限制。
相似文献
1
Non-dietary methods in the treatment of celiac disease.乳糜泻治疗中的非饮食方法。
Prz Gastroenterol. 2015;10(1):12-7. doi: 10.5114/pg.2014.47503. Epub 2015 Jan 14.
2
Non-dietary therapeutic clinical trials in coeliac disease.乳糜泻的非饮食治疗临床试验。
Eur J Intern Med. 2012 Jan;23(1):9-14. doi: 10.1016/j.ejim.2011.08.030. Epub 2011 Sep 29.
3
Evolving Therapy for Celiac Disease.乳糜泻的不断发展的治疗方法。
Front Pediatr. 2019 May 14;7:193. doi: 10.3389/fped.2019.00193. eCollection 2019.
4
Emerging drugs for celiac disease.用于乳糜泻的新型药物。
Expert Opin Emerg Drugs. 2015 Mar;20(1):129-35. doi: 10.1517/14728214.2015.985204. Epub 2014 Dec 13.
5
Rationally engineered prolyl endopeptidases from Sphingomonas capsulata with improved hydrolytic activity towards pathogenic peptides of celiac diseases.理性设计的鞘氨醇单胞菌来源脯氨酰内肽酶，对乳糜泻疾病的致病性肽具有更高的水解活性。
Eur J Med Chem. 2020 Sep 15;202:112499. doi: 10.1016/j.ejmech.2020.112499. Epub 2020 Jul 6.
6
Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.谷氨酰胺酶 ALV003 可减轻乳糜泻患者的麸质诱导的黏膜损伤。
Gastroenterology. 2014 Jun;146(7):1649-58. doi: 10.1053/j.gastro.2014.02.031. Epub 2014 Feb 25.
7
The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo.ALV003 预处理谷蛋白对乳糜泻体内免疫反应和症状的影响。
Clin Immunol. 2010 Mar;134(3):289-95. doi: 10.1016/j.clim.2009.11.001. Epub 2009 Nov 25.
8
Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue.用脯氨酰内肽酶预处理食物麸质对乳糜泻中麸质诱导的吸收不良的影响。
Clin Gastroenterol Hepatol. 2005 Jul;3(7):687-94. doi: 10.1016/s1542-3565(05)00366-6.
9
A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides.一种新型微生物谷氨酰胺降解脯氨酸内肽酶：在乳糜泻中降低谷蛋白免疫原性肽的潜在应用。
PLoS One. 2019 Jun 27;14(6):e0218346. doi: 10.1371/journal.pone.0218346. eCollection 2019.
10
Non-dietary forms of treatment for adult celiac disease.成人乳糜泻的非饮食治疗形式。
World J Gastrointest Pharmacol Ther. 2013 Nov 6;4(4):108-12. doi: 10.4292/wjgpt.v4.i4.108.
引用本文的文献
1
Clinical and immunopathological assessment of the oral mucosa in coeliac disease: a pilot study.乳糜泻患者口腔黏膜的临床与免疫病理学评估：一项初步研究。
BMC Oral Health. 2025 Jun 7;25(1):942. doi: 10.1186/s12903-025-06329-z.
2
prolyl endopeptidase in celiac disease.麸质相关疾病中的脯氨酰内肽酶。
World J Gastroenterol. 2024 Jun 28;30(24):3044-3047. doi: 10.3748/wjg.v30.i24.3044.
3
Gliadin Sequestration as a Novel Therapy for Celiac Disease: A Prospective Application for Polyphenols.麦醇溶蛋白螯合作为乳糜泻的一种新型治疗方法：多酚的前瞻性应用。
Int J Mol Sci. 2021 Jan 8;22(2):595. doi: 10.3390/ijms22020595.
4
A Comprehensive Review of Celiac Disease/Gluten-Sensitive Enteropathies.乳糜泻/麸质敏感肠病的全面综述。
Clin Rev Allergy Immunol. 2019 Oct;57(2):226-243. doi: 10.1007/s12016-018-8691-2.
5
Translational Chemistry Meets Gluten-Related Disorders.转化化学与麸质相关疾病
ChemistryOpen. 2018 Feb 27;7(3):217-232. doi: 10.1002/open.201700197. eCollection 2018 Mar.
6
Analysis of the concentration of vitamin E in erythrocytes of patients with celiac disease.乳糜泻患者红细胞中维生素E浓度的分析。
Prz Gastroenterol. 2016;11(4):282-285. doi: 10.5114/pg.2016.61354. Epub 2016 Jul 20.
本文引用的文献
1
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.乳糜泻患者摄入含谷氨酰胺酶的 gluten：一项初步研究。
World J Gastroenterol. 2013 Sep 21;19(35):5837-47. doi: 10.3748/wjg.v19.i35.5837.
2
Interest in medical therapy for celiac disease.对乳糜泻的医学治疗的兴趣。
Therap Adv Gastroenterol. 2013 Sep;6(5):358-64. doi: 10.1177/1756283X13492580.
3
Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet.乳糜泻的新兴治疗选择：无麸质饮食的潜在替代方案。
Gastroenterol Hepatol (N Y). 2012 Sep;8(9):582-8.
4
Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients.追踪麦胶过敏原污染可能在坚持饮食治疗但对治疗无反应的一部分乳糜泻患者的黏膜和临床恢复中发挥作用。
BMC Gastroenterol. 2013 Feb 28;13:40. doi: 10.1186/1471-230X-13-40.
5
Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.醋酸拉佐利特在进行麸质挑战的乳糜泻患者中的应用：一项随机安慰剂对照研究。
Aliment Pharmacol Ther. 2013 Jan;37(2):252-62. doi: 10.1111/apt.12147. Epub 2012 Nov 19.
6
Human vaccines: news.人用疫苗：新闻。
Hum Vaccin Immunother. 2012 Nov 1;8(11):1550-3. doi: 10.4161/hv.22753.
7
Are transglutaminase 2 inhibitors able to reduce gliadin-induced toxicity related to celiac disease? A proof-of-concept study.转谷氨酰胺酶 2 抑制剂能否降低与乳糜泻相关的麦胶蛋白诱导的毒性？一项概念验证研究。
J Clin Immunol. 2013 Jan;33(1):134-42. doi: 10.1007/s10875-012-9745-5. Epub 2012 Aug 10.
8
A randomized, double-blind study of larazotide acetate to prevent the activation of celiac disease during gluten challenge.醋酸拉佐利特预防麸质激发期间乳糜泻发病的随机、双盲研究。
Am J Gastroenterol. 2012 Oct;107(10):1554-62. doi: 10.1038/ajg.2012.211. Epub 2012 Jul 24.
9
Persistent duodenal intraepithelial lymphocytosis despite a long-term strict gluten-free diet in celiac disease.尽管在乳糜泻患者中进行了长期严格的无麸质饮食，但仍存在持续性十二指肠上皮内淋巴细胞增生。
Am J Gastroenterol. 2012 Oct;107(10):1563-9. doi: 10.1038/ajg.2012.220. Epub 2012 Jul 24.
10
Interactions among secretory immunoglobulin A, CD71, and transglutaminase-2 affect permeability of intestinal epithelial cells to gliadin peptides.分泌型免疫球蛋白 A、CD71 和转谷氨酰胺酶-2 之间的相互作用影响肠上皮细胞对麦胶蛋白肽的通透性。
Gastroenterology. 2012 Sep;143(3):698-707.e4. doi: 10.1053/j.gastro.2012.05.051. Epub 2012 Jun 28.
Zotero 插件